32
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Safety assessment of nanomaterials using an advanced decision-making framework, the DF4nanoGrouping

      brief-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          As presented at the 2016 TechConnect World Innovation Conference on 22–25 May 2016 in Washington DC, USA, the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) ‘Nano Task Force’ proposes a Decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) consisting of three tiers to assign nanomaterials to four main groups with possible further subgrouping to refine specific information needs. The DF4nanoGrouping covers all relevant aspects of a nanomaterial’s life cycle and biological pathways: intrinsic material properties and system-dependent properties (that depend upon the nanomaterial’s respective surroundings), biopersistence, uptake and biodistribution, and cellular and apical toxic effects. Use, release, and exposure route may be applied as ‘qualifiers’ to determine if, e.g., nanomaterials cannot be released from products, which may justify waiving of testing. The four main groups encompass (1) soluble, (2) biopersistent high aspect ratio, (3) passive, and (4) active nanomaterials. The DF4nanoGrouping foresees a stepwise evaluation of nanomaterial properties and effects with increasing biological complexity. In case studies covering carbonaceous nanomaterials, metal oxide, and metal sulfate nanomaterials, amorphous silica and organic pigments (all nanomaterials having primary particle sizes below 100 nm), the usefulness of the DF4nanoGrouping for nanomaterial hazard assessment was confirmed. The DF4nanoGrouping facilitates grouping and targeted testing of nanomaterials. It ensures that sufficient data for the risk assessment of a nanomaterial are available, and it fosters the use of non-animal methods. No studies are performed that do not provide crucial data. Thereby, the DF4nanoGrouping serves to save both animals and resources.

          Related collections

          Most cited references95

          • Record: found
          • Abstract: found
          • Article: not found

          Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment.

          Ecological risk assessors face increasing demands to assess more chemicals, with greater speed and accuracy, and to do so using fewer resources and experimental animals. New approaches in biological and computational sciences may be able to generate mechanistic information that could help in meeting these challenges. However, to use mechanistic data to support chemical assessments, there is a need for effective translation of this information into endpoints meaningful to ecological risk-effects on survival, development, and reproduction in individual organisms and, by extension, impacts on populations. Here we discuss a framework designed for this purpose, the adverse outcome pathway (AOP). An AOP is a conceptual construct that portrays existing knowledge concerning the linkage between a direct molecular initiating event and an adverse outcome at a biological level of organization relevant to risk assessment. The practical utility of AOPs for ecological risk assessment of chemicals is illustrated using five case examples. The examples demonstrate how the AOP concept can focus toxicity testing in terms of species and endpoint selection, enhance across-chemical extrapolation, and support prediction of mixture effects. The examples also show how AOPs facilitate use of molecular or biochemical endpoints (sometimes referred to as biomarkers) for forecasting chemical impacts on individuals and populations. In the concluding sections of the paper, we discuss how AOPs can help to guide research that supports chemical risk assessments and advocate for the incorporation of this approach into a broader systems biology framework.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Industrial applications of nanoparticles.

            Research efforts in the past two decades have resulted in thousands of potential application areas for nanoparticles - which materials have become industrially relevant? Where are sustainable applications of nanoparticles replacing traditional processing and materials? This tutorial review starts with a brief analysis on what makes nanoparticles attractive to chemical product design. The article highlights established industrial applications of nanoparticles and then moves to rapidly emerging applications in the chemical industry and discusses future research directions. Contributions from large companies, academia and high-tech start-ups are used to elucidate where academic nanoparticle research has revolutionized industry practice. A nanomaterial-focused analysis discusses new trends, such as particles with an identity, and the influence of modern instrument advances in the development of novel industrial products.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Rapid translocation of nanoparticles from the lung airspaces to the body.

              Nano-size particles show promise for pulmonary drug delivery, yet their behavior after deposition in the lung remains poorly understood. In this study, a series of near-infrared (NIR) fluorescent nanoparticles were systematically varied in chemical composition, shape, size and surface charge, and their biodistribution and elimination were quantified in rat models after lung instillation. We demonstrate that nanoparticles with hydrodynamic diameter (HD) less than ≈34 nm and a noncationic surface charge translocate rapidly from the lung to mediastinal lymph nodes. Nanoparticles of HD < 6 nm can traffic rapidly from the lungs to lymph nodes and the bloodstream, and then be subsequently cleared by the kidneys. We discuss the importance of these findings for drug delivery, air pollution and carcinogenesis.
                Bookmark

                Author and article information

                Contributors
                +49 621 60-56203 , robert.landsiedel@basf.com
                Journal
                J Nanopart Res
                J Nanopart Res
                Journal of Nanoparticle Research
                Springer Netherlands (Dordrecht )
                1388-0764
                1572-896X
                9 May 2017
                9 May 2017
                2017
                : 19
                : 5
                : 171
                Affiliations
                [1 ]ISNI 0000 0001 1551 0781, GRID grid.3319.8, Experimental Toxicology and Ecology, , BASF SE, ; Carl-Bosch-Strasse 38, D-67056 Ludwigshafen, Germany
                [2 ]ISNI 0000 0001 1551 0781, GRID grid.3319.8, Regulatory Toxicology, , BASF SE, ; 67056 Ludwigshafen, Germany
                [3 ]ISNI 0000 0001 1551 0781, GRID grid.3319.8, Advanced Materials Research, , BASF SE, ; 67056 Ludwigshafen, Germany
                [4 ]Scientific Consultancy—Animal Welfare, Hallstattfeld 16, 85579 Neubiberg, Germany
                Author information
                http://orcid.org/0000-0003-3756-1904
                Article
                3850
                10.1007/s11051-017-3850-6
                5423989
                28553159
                97b1bb14-ac25-4c41-853d-95547d4d678e
                © The Author(s) 2017

                Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 2 August 2016
                : 10 April 2017
                Categories
                Brief Communication
                Custom metadata
                © Springer Science+Business Media Dordrecht 2017

                Nanotechnology
                grouping,hazard and risk assessment,realistic exposure scenarios,integrated approach for testing and assessment (iata),in vitro effects,nanomaterials,societal implications

                Comments

                Comment on this article